Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DESTINY-HF: Valsartan QD vs BID in Heart Failure
NCT00294086Phase 2Completed
- Sponsor
- Novartis
- Start
- Dec 2005
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valsartan in chronic heart failure (CHF), sponsored by Novartis. Started Dec 2005; status: completed.
02
Drugs
valsartan
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT00294086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00294086.